ANALYTIC SPECTRAL METHOD OF ALTERNANS PROCESSING; CH 2000 CARDIAC DIAGNOSTIC SYSTEM; HEARTWAVE ALTERNANS PROCESSING SYS

Computer, Diagnostic, Programmable

CAMBRIDGE HEART, INC.

The following data is part of a premarket notification filed by Cambridge Heart, Inc. with the FDA for Analytic Spectral Method Of Alternans Processing; Ch 2000 Cardiac Diagnostic System; Heartwave Alternans Processing Sys.

Pre-market Notification Details

Device IDK003492
510k NumberK003492
Device Name:ANALYTIC SPECTRAL METHOD OF ALTERNANS PROCESSING; CH 2000 CARDIAC DIAGNOSTIC SYSTEM; HEARTWAVE ALTERNANS PROCESSING SYS
ClassificationComputer, Diagnostic, Programmable
Applicant CAMBRIDGE HEART, INC. 20310 SW 48TH ST. Ft. Lauderdale,  FL  33332
ContactJohn Greenbaum
CorrespondentJohn Greenbaum
CAMBRIDGE HEART, INC. 20310 SW 48TH ST. Ft. Lauderdale,  FL  33332
Product CodeDQK  
CFR Regulation Number870.1425 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2000-11-13
Decision Date2001-01-18

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.